Alissa Loren Briggs

Title: Alissa Loren Briggs: Innovator in Cancer Treatment

Introduction

Alissa Loren Briggs is a notable inventor based in San Jose, California. She has made significant contributions to the field of cancer treatment through her innovative work in multi-specific antibodies. Her research focuses on developing methods to target both cellular efflux pumps and cancer-associated antigens.

Latest Patents

Alissa holds a patent for "Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto." This patent provides multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen. It also includes pharmaceutical compositions, nucleic acids, recombinant expression vectors, cells, and kits that incorporate or encode these multi-specific antibodies. The methods described in her patent aim to treat subjects for cancer by administering these innovative antibodies.

Career Highlights

Alissa is associated with the William Robert Arathoon Living Trust Dated August 29, 2016. Her work in this organization has allowed her to focus on groundbreaking research in cancer therapies. She has successfully developed methods for generating multi-specific antibodies and related reagents, including genetically modified cell lines.

Collaborations

Alissa collaborates with notable individuals in her field, including William Robert Arathoon and Evan Matthew Bishop. Their combined expertise contributes to the advancement of cancer treatment methodologies.

Conclusion

Alissa Loren Briggs is a pioneering inventor whose work in multi-specific antibodies is paving the way for innovative cancer treatments. Her contributions are significant in the ongoing fight against cancer, showcasing the importance of research and collaboration in medical advancements.